RecruitingMigraine
Study of EVO756 in Adults With Migraine
Eligible age
18–64 yrs
Accepts
All genders
Locations
16 states
Healthy volunteers
No
See if you qualify for this study
Answer a few quick questions about your location and health. Takes about a minute.
About this study
This study will evaluate the efficacy and safety of EVO756 against placebo in adults with migraine.
Sponsor: Evommune, Inc.
Where it's recruiting
Arizona
Chandler
California
Buena Park · Fresno · Los Angeles · Walnut Creek
Connecticut
New Haven · Stamford
Florida
Jacksonville · Miami · Orlando · Tampa …
Georgia
Atlanta · Decatur
Massachusetts
Foxborough · Westborough
Michigan
Ann Arbor · Farmington Hills
New Jersey
Toms River
New York
Amherst
North Carolina
Asheville · Raleigh
Ohio
Canton
South Carolina
Charleston
Source: ClinicalTrials.gov · NCT07616128 · last updated 2026-10-02